parainfluenza viruses

Also found in: Medical.
Related to parainfluenza viruses: HPIV

par·a·in·flu·en·za vi·rus·es

n., pl. virus de parainfluenza, virus asociados con infecciones respiratorias, esp. en los niños.
References in periodicals archive ?
TM] is an investigational drug which is designed to target the receptor for parainfluenza viruses and is being evaluated in a Phase 2 trial for the treatment of severe parainfluenza infection in immunocompromised patients.
Respiratory syncytial virus (RSV), human metapneumovirus, parainfluenza viruses, and coronaviruses co-circulate with influenza during the fall and winter, while adenovirus and rhinovirus circulate throughout the year.
Targets included human rhinovirus, enterovirus, influenza A and B viruses, parainfluenza viruses 1-4, respiratory syncytial virus A and B, adenovirus, bocavirus, human metapneumovirus, human coronavirus OC43, and human coronavirus 229E/NL63.
Indirect immunofluorescence assays were negative for likely viruses including influenza A and B, respiratory syncytial virus, adenovirus, and parainfluenza viruses types 1 to 3.
Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children.
Human metapneumovirus is related to the respiratory syncytial virus, measles, mumps and parainfluenza viruses.
Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients.
United States Department of Health and Human Services (Washington, DC) has patented a chimeric parainfluenza viruses (PIVs) that incorporate a PIV vector genome or antigenome and one or more antigenic determinant(s) of a heterologous PIV or non-PIV pathogen.
The drug candidate works by preventing all types and strains of influenza virus from entering the airway epithelial cells, including avian influenza as well as parainfluenza viruses.
LTB generally results from an infection with parainfluenza viruses.
Table 2 illustrates the distribution of the 71 viruses detected, which were RSV (n = 52; 73%); influenza A (n = 9; 13%); parainfluenza viruses, types 2 and 3 (n = 4; 6%); adenoviruses, not typed (n = 4; 6%); and enteroviruses, not typed (n = 2; 3%).
Members of the paramyxovirus family include the parainfluenza viruses (which cause respiratory infections), the mumps virus, and the Newcastle disease virus (which affects birds).